daunorubicin has been researched along with Hematologic Malignancies in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Goliaei, B; Habibi-Kelishomi, Z; Homami, E; Shariatpanahi, SP | 1 |
Abu-Sbeih, H; Ali, FS; Curry, JL; Foo, WC; Ge, PS; Luo, W; Neelapu, SS; Okhuysen, PC; Richards, DM; Tang, T; Wang, Y; Westin, JR | 1 |
Banerjee, K; Gibbons, JA; Marier, JF; Vasilinin, G; Wang, Q | 1 |
Bao, W; Chen, B; Liu, R; Wang, F; Xia, G | 1 |
Bonkovsky, HL; D'Agostino, RB; Hundley, WG; Jordan, JH; Lamar, ZS; Meléndez, GC; Poole, LB; Porosnicu, M; Vera, T; Whitlock, MC | 1 |
Chen, B; Cheng, J; Li, J; Liu, L; Wang, J; Wang, X; Wei, H; Wu, W; Xia, G; Xu, C; Xu, W; Yang, L; Yang, M; Zhang, Y | 1 |
Davies, JH; Evans, BA; Gregory, JW; Jenney, ME | 1 |
Ogawa, M | 1 |
Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
He, Q; Liu, J; Tan, D; Xie, Z; Zhong, M | 1 |
2 review(s) available for daunorubicin and Hematologic Malignancies
Article | Year |
---|---|
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 2003 |
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
8 other study(ies) available for daunorubicin and Hematologic Malignancies
Article | Year |
---|---|
Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells).
Topics: Blood Cells; Daunorubicin; Hematologic Neoplasms; Humans; Treatment Outcome; U937 Cells | 2023 |
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.
Topics: Adult; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Cohort Studies; Cytarabine; Daunorubicin; Female; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Immunohistochemistry; Immunotherapy, Adoptive; Incidence; Male; Middle Aged; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Thioguanine | 2019 |
Population Pharmacokinetics and Exposure-Response Analyses for CPX-351 in Patients With Hematologic Malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Renal Insufficiency; Treatment Outcome | 2019 |
Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Daunorubicin; Drug Screening Assays, Antitumor; Hematologic Neoplasms; Humans; K562 Cells; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Polyesters; Polylysine; Transferrin; Tumor Cells, Cultured | 2019 |
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bilirubin; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Hematologic Neoplasms; Humans; Idarubicin; Male; Middle Aged; Oxidative Stress; Retrospective Studies; Stroke Volume; Ventricular Dysfunction, Left | 2015 |
Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
Topics: Analysis of Variance; Animals; Biocompatible Materials; Body Weight; Daunorubicin; Female; Hematologic Neoplasms; Hemolysis; Humans; Injections, Intraperitoneal; Lethal Dose 50; Magnetite Nanoparticles; Male; Mice; Micronucleus Tests | 2010 |
In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Diseases, Metabolic; Child; Daunorubicin; Etoposide; Female; Glucocorticoids; Hematologic Neoplasms; Humans; Osteoblasts; Stem Cells; Tumor Cells, Cultured; Vincristine | 2002 |
[Changes of serum myocardial enzymes in patients with malignant hematologic diseases].
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Creatine Kinase; Daunorubicin; Hematologic Neoplasms; Humans; Isoenzymes; L-Lactate Dehydrogenase | 1998 |